Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Machine Learning Model Accurately Identifies High-Risk Surgical Patients

By HospiMedica International staff writers
Posted on 18 Jul 2023

Prior to the COVID-19 pandemic, complications occurring 30 days post-surgery were the third leading cause of death worldwide, claiming approximately 4. More...

2 million lives annually. Recognizing patients at high risk for post-surgical complications is crucial to improving survival rates and reducing healthcare costs. Researchers have now employed machine learning to develop and implement an efficient, adaptable model for identifying hospitalized patients at high risk for post-surgical complications.

Researchers and physicians at the University of Pittsburgh (Pittsburgh, PA, USA) and UPMC (Pittsburgh, PA, USA) developed this model by training the algorithm on the medical records of over 1.25 million surgical patients. The focus of the model was on mortality and the occurrence of major cerebral or cardiac events, such as stroke or heart attack, following surgery. The model was then validated using the records of another 200,000 surgical patients from UPMC. After validation, the model was implemented across 20 UPMC hospitals. Each morning, the program reviews the electronic medical records of patients scheduled for surgery and flags those identified as high risk. This alert enables clinical teams to improve care coordination and introduce prehabilitation measures before surgery, such as healthier lifestyle choices or a referral to the UPMC Center for Perioperative Care, thus lowering the risk of complications. Clinicians can also activate the model on demand at any time.

Additionally, the research team compared their model with the industry standard, the American College of Surgeon’s National Surgical Quality Improvement Program (ACS NSQIP), to further gauge its effectiveness. The ACS NSQIP, used at hospitals nationwide, requires manual input of patient information by clinicians and is unable to make predictions if data is missing. The researchers found their model to be more effective at identifying high-risk patients than the ACS NSQIP. As the model continues to be fine-tuned and developed, the researchers plan to train the program to predict the likelihood of other complications, such as sepsis and respiratory issues, that often result in prolonged hospital stays after surgery.

“We designed our model with the health care worker in mind,” said Aman Mahajan, M.D., Ph.D., M.B.A., chair of Anesthesiology and Perioperative Medicine, Pitt School of Medicine, and director of UPMC Perioperative and Surgical Services. “Since our model is completely automated and can make educated predictions even if some data are missing, it adds almost no additional burden to clinicians while providing them a reliable and useful tool.”

Related Links:
University of Pittsburgh 
UPMC 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.